Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study

Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study

This randomized controlled pharmacokinetic based study will be carried out on patients with both sexes and various ages, plasma triglycerides levels, clinical health disorders and using different agents for treatment of their hyperlipidemia in order to access the optimal drug therapy with best cost effectiveness in the elderly cases under investigation.

Inclusion Criteria:

• Patients of dyslipidemia with high triglyceride level (200 to 499 mg/100 ml).
• Total cholesterol level more than 200 mg/100 ml
• Male and female
• Age 35 - 70 years

Exclusion Criteria:

• - Hypersensitivity of drugs
• Liver toxicity
• -Patients suffering from renal dysfunction